by [email protected] | May 20, 2019 | Mental Health, Neurological, Publication
Abstract Authors: Shah A, Xie L, Kariburyo F, Zhang Q, Gore M Introduction: Long-acting injectable (LAI) antipsychotic use may reduce healthcare resource utilization compared with oral antipsychotic use by improving adherence and reducing dosing frequency. Our goal...
by [email protected] | May 19, 2019 | Mental Health, Neurological, Publication
Abstract Authors: Huang A, Amos TB, Joshi K, Wang L, Nash A Background: Schizophrenia is a serious public health problem that affects ∼1% of the US population. Aims: To examine treatment patterns and evaluate healthcare resource utilization (HRU) and costs...
by [email protected] | May 18, 2019 | Mental Health, Publication
Abstract Authors: Pesa JA, Doshi D, Wang L, Yuce H, Baser O. Objective: To compare all-cause health care utilization and costs between patients with schizophrenia treated with once monthly paliperidone palmitate (PP1M; Invega Sustenna) and atypical oral antipsychotic...
by [email protected] | May 16, 2019 | Mental Health, Publication
Abstract Authors: Baser O, Xie L, Pesa J, Durkin M. Objective: This study aimed to compare real world healthcare costs and resource utilization between patients with schizophrenia treated with paliperidone palmitate long-acting injection (PP) and oral atypical...
by [email protected] | May 14, 2019 | Mental Health, Pain / Palliative, Publication
Abstract Authors: Baser O, Xie L, Mardekian J, Schaaf D, Wang L, Joshi AV. Objective: Evaluate prevalence and risk-adjusted healthcare costs of diagnosed opioid abuse in the national Veterans Health Administration (VHA). Costs were compared between patients with...
by [email protected] | May 12, 2019 | Mental Health, Publication
Abstract Authors: Xie L, Kariburyo MF, Du J, Wang Y. Objective: To examine the economic burden and health care utilizations of schizophrenia in the U.S. veteran population. Methods: A retrospective database analysis was performed using the Veterans Health...
